Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative illness, characterized by memory loss and cognitive decline, accounting for 60-80% of dementia cases. AD is characterized by senile plaques made up of amyloid β (Aβ) protein, intracellular neurofibrillary tangles caused by hyperphosphorylation of tau protein linked with microtubules, and neuronal loss. Currently, therapeutic treatments and nanotechnological developments are effective in treating the symptoms of AD, but a cure for the illness has not yet been found. Recently, the increased study of extracellular vesicles (EVs) has led to a growing awareness of their significant involvement in neurodegenerative disorders, including AD. Exosomes are small extracellular vesicles that transport various components including messenger RNAs, non-coding RNAs, proteins, lipids, DNA, and other bioactive compounds from one cell to another, facilitating information transmission and material movement. There is growing evidence indicating that exosomes have complex functions in AD. Exosomes may have a dual role in Alzheimer's disease by contributing to neuronal death and also helping to alleviate the pathological progression of the disease. Therefore, the primary aim of this review is to outline the updated understandings on exosomes biogenesis and many functions of exosomes in the generation, conveyance, distribution, and elimination of hazardous proteins related to Alzheimer's disease. This review is intended to provide novel insights for understanding the development, specific treatment, and early detection of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They seem to display a dual function in both expediting disease progression (e.g., triggering inflammation and oxidative stress) and slowing it down (Aβ and tau clearance) [111].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Three main roles have been identified for exosomes: (i) to establish communication between cells and tissues by exchange of their intrinsic content; (ii) as diagnostic biomarkers; (iii) as DDS due to their properties (high stability, minimal immunogenicity, ease in crossing biological barriers, target specific cells or tissues, etc.) [111,112].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
The cited source says what the claim attributes to it.
In the citing paper
“Exosomes are extracellular vesicles with a diameter of around 30–150 nm, secreted by most cell types in the human body, and often found in physiological fluids such as blood, CSF, urine, and saliva [111,112].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
The cited source says what the claim attributes to it.
In the citing paper
“It has been demonstrated that exosomes are capable of transporting both pathogenic molecules (e.g., Aβ, tau) and therapeutic compounds.”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [91]
The cited source says what the claim attributes to it.
In the citing paper
“Their role in AD is dual: although they contribute to the disease’s pathogenesis, they also assist in the clearance of toxic protein aggregates and modulate neuroinflammation [91, 92].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–249 of 249
Estrada, L. D., Oliveira-Cruz, L., & Cabrera, D. (2018) · Current Protein & Peptide Science · doi:10.2174/1389203719666171129094937 · Cited by 59 · cited 1×
“132 Collectively, these results suggest that exosomes may transport pathogenic proteins associated with Alzheimer’s disease and lead to dysfunction in neuronal activity.”
BackgroundA Pilot Study of Urinary Exosomes in Alzheimer’s Disease
Sun, R., Wang, H., Shi, Y., Gao, D., Sun, Z., Chen, Z., Jiang, H., & Zhang, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505851 · Cited by 59
Self-citationGomes, P., Tzouanou, F., Skolariki, K., Vamvaka-Iakovou, A., Noguera-Ortiz, C., Tsirtsaki, K., Waites, C. L., Vlamos, P., Sousa, N., Costa-Silva, B., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114183 · Cited by 55
Insight into the Role of Extracellular Vesicles in Lysosomal Storage Disorders
Tancini, B., Buratta, S., Sagini, K., Costanzi, E., Delo, F., Urbanelli, L., & Emiliani, C. (2019) · Genes · doi:10.3390/genes10070510 · Cited by 54 · cited 1×
“115,116 Conversely, inhibiting autophagic trafficking facilitates exosome secretion.”
BackgroundZHU, Y., LI, C., SUN, A., WANG, Y., & ZHOU, S. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2179 · Cited by 53
MicroRNA-613 regulates the expression of brain-derived neurotrophic factor in Alzheimer's disease
Li, W., Li, X., Xin, X., Kan, P.-C., & Yan, Y. (2016) · BioScience Trends · doi:10.5582/bst.2016.01127 · Cited by 53
Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology?
Kacířová, M., Zmeškalová, A., Kořínková, L., Železná, B., Kuneš, J., & Maletínská, L. (2020) · Clinical Science · doi:10.1042/cs20191313 · Cited by 53 · cited 1×
“89–91 More study has focused on exosomes as neuron-glial cell communication mediators.”
BackgroundSize Exclusion Chromatography: A Simple and Reliable Method for Exosome Purification
Lobb, R. J., & Möller, A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7253-1_9 · Cited by 52 · cited 1×
“34 Nevertheless, additional procedures are required when using SEC to prevent sample-lipoprotein interference and protein aggregation.”
MethodExosome-encapsulated microRNAs as promising biomarkers for Alzheimer’s disease
Chen, J.-J., Yang, G., Yan, Q., Zhao, J., & Li, S. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0001 · Cited by 51
Dysfunction of the Blood-brain Barrier in Cerebral Microbleeds: from Bedside to Bench
Wang, H., Zhang, C., Qiu, Y., Chen, A., Li, Y., & Hu, B. (2021) · Aging and Disease · doi:10.14336/ad.2021.0514 · Cited by 50
Role of Pro-Inflammatory Cytokines and Vitamin D in Probable Alzheimer's Disease with Depression
Banerjee, A., Khemka, V. K., Roy, D., Dhar, A., Roy, T. K. S., Biswas, A., Mukhopadhyay, B. K., & Chakrabarti, S. (2017) · Aging and Disease · doi:10.14336/ad.2016.1017 · Cited by 49 · cited 1×
“89–91 More study has focused on exosomes as neuron-glial cell communication mediators.”
BackgroundLi, Y., Meng, S., Wu, D., Xia, M., Dong, L., Zhao, Y., Ling, S., He, J. N., Xue, X., Chen, X., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13846 · Cited by 49 · cited 1×
“230 It is also necessary to use synthetic liposomes consisting of glycosphingolipids to collect Aβ and presenilin instead of natural exosomes.”
BackgroundSerum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
Zhang, M., Han, W., Xu, Y., Li, D., & Xue, Q. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s290925 · Cited by 48 · cited 1×
“3) Inconsistent experimental results due [191] miR-let-7d-5p, miR-let-7g-5p, miR-15b-5p, miR-142-3p, miR-191-5p, miR-545-3p, miR-301a-3p Plasma Downregulated These 7 signature miRNAs are downregulated in the plasma of AD patients and can discriminate AD individuals from healthy controls.”
BackgroundSmall but Mighty—Exosomes, Novel Intercellular Messengers in Neurodegeneration
Kumari, M., & Anji, A. (2022) · Biology · doi:10.3390/biology11030413 · Cited by 47 · cited 1×
“44 Extracellular deposits seen in the brains of Alzheimer’s disease patients, known as amyloid plaques, mostly consist of Aβ.”
BackgroundWeng, S., Lai, Q.-L., Wang, J., Zhuang, L., Cheng, L., Mo, Y., Liu, L., Zhao, Z., Zhang, Y., & Qiao, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.899944 · Cited by 47 · cited 1×
“93 Research indicates that Aβ buildup and tau hyperphosphorylation activate microglia and astrocytes, leading to inflammation.”
BackgroundAnalysis of Serum miRNAs in Alzheimer’s Disease
Liu, L., Dai, W.-Z., Zhu, X., & Ma, T. (2021) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175211021712 · Cited by 46
Pacheco-Quinto, J., Clausen, D., Pérez-González, R., Peng, H., Meszaros, A., Eckman, C. B., Levy, E., & Eckman, E. A. (2019) · The FASEB Journal · doi:10.1096/fj.201801319r · Cited by 45 · cited 2×
“54 Exosomes regularly contain APP, CTFs-APP, and various proteases involved in APP processing.”
BackgroundResultPan, J., He, R., Huo, Q., Shi, Y., & Zhao, L. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03076-1 · Cited by 45
Neuroprotection mediated by cystatin C-loaded extracellular vesicles
Pérez‐González, R., Sahoo, S., Gauthier, S. A., Kim, Y., Li, M., Kumar, A. R., Pawlik, M., Benussi, L., Ghidoni, R., & Levy, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-47524-7 · Cited by 43 · cited 1×
“Exosomes include proteins with several powerful protective roles for neurons, such as Cystatin C. 133,134 Neprilysin (NEP) and insulin-degrading enzyme (IDE), two enzymes involved in the breakdown of Aβ, are also found in exosomes.”
BackgroundHuang, S. Q., Liao, X., Wu, J., Zhang, X., Li, Y., Xiang, D., & Luo, S. (2022) · FEBS Letters · doi:10.1002/1873-3468.14336 · Cited by 43 · cited 1×
“138 Furthermore, TREM2 may influence tau pathology along with its functions in Aβ clearance.”
BackgroundExosomal and vesicle‐free tau seeds—propagation and convergence in endolysosomal permeabilization
Polanco, J. C., & Götz, J. (2022) · The FEBS Journal · doi:10.1111/febs.16055 · Cited by 42 · cited 1×
“69 Aβ enhances the seeding activity of the majority of the exosomal tau produced by AD synapses, which is oligomeric and has its C-terminal truncated form.”
BackgroundSandau, U. S., McFarland, T. J., Smith, S. J., Galasko, D. R., Quinn, J. F., & Saugstad, J. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.864022 · Cited by 42 · cited 1×
“[213]”
The prion-like transmission of tau oligomers via exosomes
Jackson, N. A., Guerrero-Muñoz, M. J., & Castillo-Carranza, D. L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.974414 · Cited by 42
The Dichotomous Role of Extracellular Vesicles in the Central Nervous System
Graykowski, D. R., Wang, Y.-Z., Upadhyay, A., & Savas, J. N. (2020) · iScience · doi:10.1016/j.isci.2020.101456 · Cited by 39
Wang, R., Li, J., Zhang, X., Zhang, X., Zhang, X., Zhu, Y., Chen, C., Liu, Z., Wu, X., Wang, D., et al. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112362 · Cited by 39
Hao, Y., Su, C., Liu, X., Sui, H., Shi, Y., & Zhao, L. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212770 · Cited by 39 · cited 2×
“[231] Neuroblastoma APP transgenic mice Reduce amyloid buildup, A β -mediated synaptotoxicity, and A β levels in the hippocampal tissues.”
BackgroundLiu, Q., & Lei, C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111187 · Cited by 38
Wang, Z., Qin, W., Wei, C., Tang, Y., Zhao, L., Jin, H. M., Li, Y., Wang, Q., Luan, X., He, J., et al. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4881 · Cited by 37 · cited 1×
“[199] miR-206 Plasma Upregulated The level of this miRNA is increased in the plasma of AD patients and can predict cognitive decline using the MMSE test.”
MethodYang, J. S., Kim, J. Y., Lee, J. C., & Moon, M. H. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.04.069 · Cited by 37 · cited 1×
“117 118–121 Furthermore, the presence of nanoparticles, mechanical damage, or chemicals has been shown to cause oxidative stress, leading to an increase in the quantity of exosomes, which may also be accompanied by morphological alterations.”
BackgroundExosomes Mediate APP Dysregulation via APP-miR-185-5p Axis
Ding, L., Yang, X., Xia, X., Li, Y., Wang, Y., Li, C., Sun, Y., Gao, G., Zhao, S., Sheng, S., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.793388 · Cited by 37 · cited 1×
“60 More data is needed to establish that indirect regulation has expanded the complexity of APP metabolism exosomes.”
BackgroundAccumulation of the Amyloid-β Precursor Protein in Multivesicular Body-like Organelles
Verbeek, M. M., Otte-Höller, I., Fransen, J. A. M., & de Waal, R. M. W. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000509 · Cited by 36 · cited 1×
“13 Exosomes associated with AD were first discovered while studying the buildup of APP cleavage in MVBs, 14,15 which are considered as progenitors of exosomes.”
BackgroundAlteration of Neural Pathways and Its Implications in Alzheimer’s Disease
Kim, S., Nam, Y., Kim, H. S., Jung, H., Jeon, S. G., Hong, S. B., & Moon, M. (2022) · Biomedicines · doi:10.3390/biomedicines10040845 · Cited by 36 · cited 1×
“143 More and more research is focusing on exosomes as potential biomarkers to differentiate between healthy and diseased states, due to their unique biological properties.”
BackgroundKumar, S., & Reddy, P. H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166052 · Cited by 35
In vivo evidence of exosome-mediated Aβ neurotoxicity
Elsherbini, A. M., Qin, H., Zhu, Z., Tripathi, P., Crivelli, S. M., & Bieberich, E. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00981-y · Cited by 34 · cited 1×
“85,86 Interestingly, peripheral exosomal contents may potentiate CNS inflammation, which may play a part in explaining how a peripheral pro-inflammatory state such as depression, obesity, diabetes can be risk factors for AD.”
BackgroundZhao, X., Wang, S., & Sun, W. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8920 · Cited by 30
Exosomes Secreted from HEK293-APP Swe/Ind Cells Impair the Hippocampal Neurogenesis
Zheng, T., Pu, J., Chen, Y., Guo, Z., Pan, H., Zhang, L., Zhang, H., Sun, B., & Zhang, B. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9713-1 · Cited by 28
Chen, Z., Morales, J. E., Avci, N. G., Guerrero, P. A., Rao, G., Seo, J. H., & McCarty, J. H. (2020) · Development · doi:10.1242/dev.193094 · Cited by 28 · cited 1×
“123,124 Research indicates that microglia-produced inflammatory cytokines, regulated by Amyloid-β protein, accelerate AD development.”
BackgroundSelf-citationDong, Z., Gu, H., Guo, Q., Liu, X., Li, F., Liu, H., Sun, L., Ma, H., & Zhao, K. (2022) · Cells · doi:10.3390/cells11233830 · Cited by 27 · cited 1×
“[203] miR-342-3p, miR-141-3p, miR-342-5p, miR-23b-3p, miR-125b-5p, miR-24–3p, miR152–3p Plasma (Exosome) Downregulated These miRNAs can predict AD status.”
BackgroundGlebov, K., & Walter, J. (2012) · Neurodegenerative Diseases · doi:10.1159/000332595 · Cited by 25
Lee, B., Kim, M., Lee, S. Y., Son, S. J., Hong, C. H., & Jung, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061642 · Cited by 23
Fricke, F., Gebert, J. F., Kopitz, J., & Plaschke, K. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00905-3 · Cited by 23 · cited 2×
“88 It was demonstrated that proinflammatory exosomes could cross the blood– brain barrier and trigger neuroinflammation when injected intravenously.”
BackgroundYuyama, K., & Igarashi, Y. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10066-8 · Cited by 23 · cited 1×
“61 Research suggests that GM1 ganglioside, found in GSLs, may bind to Aβ and enhance aggregation.”
BackgroundExploring the role of mitochondrial proteins as molecular target in Alzheimer’s disease
Chadha, S., Behl, T., Sehgal, A., Kumar, A., & BUNGAU, S. G. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.008 · Cited by 20 · cited 1×
“42,43 The release of amyloid-β protein from cultured cells and the accumulation of exosomal proteins like Alix and Flotillin-1 surrounding amyloid plaques in AD patients demonstrate the link between exosomes and the illness.”
BackgroundJeyaraman, M., Rajendran, R. L., Muthu, S., Jeyaraman, N., Sharma, S., Jha, S. K., Muthukanagaraj, P., Hong, C. M., da Fonseca, L. F., Lana, J. F., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17808 · Cited by 17
TREM2 and microglia exosomes: a potential highway for pathological tau
Jain, N., & Ulrich, J. D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00581-5 · Cited by 16
Does metabolic failure at the synapse cause Alzheimer’s disease?
Engel, P. A. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.10.013 · Cited by 15
Krishna, G., Santhoshkumar, R., Sivakumar, P. T., Alladi, S., Mahadevan, A., Dahale, A. B., Arshad, F., & Subramanian, S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220829 · Cited by 15 · cited 2×
“In a study by Krishna et al, 160 the synaptic and organellar markers in AD and frontotemporal dementia (FTD) are investigated by assessing the levels of synaptic protein, neurogranin (Ng), and organellar proteins, mitofusin-2 (MFN-2), lysosomal associated membrane protein-2 (LAMP2), and golgin A4…”
BackgroundHsu, M., Chiu, C.-C., Wang, J.-Y., Huang, C., Huang, Y., Liou, J.-C., Chen, C., Chen, H., & Cheng, C. (2018) · Nanomaterials · doi:10.3390/nano8050310 · Cited by 14 · cited 1×
“37 Because of its many benefits, including high-purity separation, economy, and reduced processing time, microfluidics has recently emerged as a cutting-edge method for isolating exosomes.”
Method(2018) · doi:10.3967/bes2018.011 · cited 1×
“156 Yang et al 157 measured serum miR-135a, −193b, and −384 levels using qRT-PCR in 2018.”
Method
Cited by
Serrano, D. R., Juste, F., Anaya, B. J., Ramirez, B. I., Sánchez-Guirales, S. A., Moyota, J. M. Q., Hernandez, E. M., Simon, J. A., Trallero, J. M., Serrano, C., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101336 · Cited by 143
“Neurogenetic Disorders: Exosome-based strategies delivering CRISPR/Cas9, mRNA, or RNAi have been tested in mouse models of Huntington’s disease and Amyotrophic Lateral Sclerosis, enabling gene modulation within the brain and prolonging survival in early studies [82].”
Kochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60
The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease
Daksh, R., Mathew, M. S., Bosco, A. M., Sojan, C., Tom, A. A., Bojja, S. L., & Nampoothiri, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151526 · Cited by 18
Shahlaei, M., Afkhami, H., Ahmadieh-Yazdi, A., Mirmazloumi, S. H., Sahraei, S. S., Akbari, M., Yang, P., Manoochehri, H., Tanzadehpanah, H., Mahaki, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118548 · Cited by 22
An Update of Salivary Biomarkers for the Diagnosis of Alzheimer’s Disease
Guo, H., RuiHuan, Y., Cheng, W., Li, Q., & Du, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052059 · Cited by 17
“Exosomes are vehicles for proteins, DNA, mRNA, miRNA, and other non-coding RNAs (ncRNAs) and are involved in A β -amyloid deposits, the formation of NFTs, neuroinflammation, and neuronal dysfunction in AD [95,96].”
Metadata
- Authors
- Sun, M., & Chen, Z.
- Affiliations
- Changzhou No.2 People's Hospital (CN)
- Corresponding author
- Sun, Mingyue
- Chen, Zhuoyou
- Venue
- Journal of Inflammation Research
- Publisher
- Informa UK Limited
- Published
- 2024-06
- Volume
- Volume 17
- Pages
- 3921-3948
- ISSN
- 1178-7031 (ISSN-L)
- PMC
- PMC11193473
- OpenAlex
- W4399787176
- Cited by
- 39
- References
- 249
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Inflammation Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- exosomes, Alzheimer's disease, extracellular vesicles, amyloid-beta, tau hyperphosphorylation, neurofibrillary tangles, exosome biogenesis, intercellular communication, neurodegeneration, early detection, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.